



Shared by @SciImmunology ↗

pEVAC-PS is the first experimental vaccine designed completely with AI to be tested in a human trial.
Needle-free intradermal delivery of this novel computationally designed PanSarbeco vaccine was safe and well tolerated. Although immunogenicity was modest in the context of substantial pre-existing immunity, participants developed measurable responses to


